MetLife Investment Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.98M Sell
24,278
-497
-2% -$143K 0.04% 436
2025
Q1
$7.64M Sell
24,775
-375
-1% -$116K 0.04% 430
2024
Q4
$8.87M Buy
25,150
+2,168
+9% +$765K 0.05% 296
2024
Q3
$8.24M Sell
22,982
-364
-2% -$130K 0.05% 306
2024
Q2
$7.44M Sell
23,346
-2,436
-9% -$776K 0.04% 318
2024
Q1
$5.92M Sell
25,782
-649
-2% -$149K 0.04% 408
2023
Q4
$5.81M Sell
26,431
-431
-2% -$94.8K 0.04% 381
2023
Q3
$6.07M Sell
26,862
-1,180
-4% -$267K 0.05% 333
2023
Q2
$6.19M Buy
28,042
+113
+0.4% +$24.9K 0.05% 347
2023
Q1
$6.25M Sell
27,929
-748
-3% -$168K 0.05% 343
2022
Q4
$7.97M Sell
28,677
-537
-2% -$149K 0.06% 258
2022
Q3
$6.12M Sell
29,214
-232
-0.8% -$48.6K 0.05% 323
2022
Q2
$6.94M Buy
29,446
+337
+1% +$79.4K 0.05% 283
2022
Q1
$5.22M Buy
29,109
+7,283
+33% +$1.31M 0.03% 495
2021
Q4
$4.72M Buy
21,826
+259
+1% +$56K 0.04% 426
2021
Q3
$3.98M Sell
21,567
-817
-4% -$151K 0.04% 483
2021
Q2
$4.02M Sell
22,384
-625
-3% -$112K 0.04% 503
2021
Q1
$3.85M Sell
23,009
-1,310
-5% -$219K 0.04% 529
2020
Q4
$3.69M Sell
24,319
-1,109
-4% -$168K 0.03% 515
2020
Q3
$2.57M Sell
25,428
-709
-3% -$71.6K 0.03% 615
2020
Q2
$3.16M Buy
26,137
+949
+4% +$115K 0.04% 505
2020
Q1
$2.39M Hold
25,188
0.03% 538
2019
Q4
$2.22M Sell
25,188
-316
-1% -$27.8K 0.02% 767
2019
Q3
$2.03M Sell
25,504
-452
-2% -$36K 0.02% 785
2019
Q2
$2.03M Sell
25,956
-695
-3% -$54.3K 0.02% 809
2019
Q1
$3.13M Buy
26,651
+74
+0.3% +$8.69K 0.03% 591
2018
Q4
$2.89M Sell
26,577
-93
-0.3% -$10.1K 0.04% 564
2018
Q3
$3.41M Sell
26,670
-697
-3% -$89.1K 0.03% 579
2018
Q2
$3.1M Buy
27,367
+383
+1% +$43.3K 0.04% 585
2018
Q1
$3.03M Sell
26,984
-356
-1% -$40K 0.04% 606
2017
Q4
$4.05M Buy
+27,340
New +$4.05M 0.05% 459